-+ 0.00%
-+ 0.00%
-+ 0.00%

NNZ-2591 PMS Phase 2 trial published in Neurology Genetics

ASX·01/06/2026 23:21:43

The content of this announcement was automatically generated by machine and is for reference only. The original announcement can be viewed by clicking on the link below.